Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma ; volume:72 ; number:10 ; day:29 ; month:6 ; year:2023 ; pages:3175-3189 ; date:10.2023
Cancer immunology immunotherapy ; 72, Heft 10 (29.6.2023), 3175-3189, 10.2023
- Urheber
-
Takei, Jun
Kamata, Yuko
Tanaka, Toshihide
Fukasawa, Nei
Gomisawa, Kazutaka
Satake, Mari
Mori, Ryosuke
Yamamoto, Yohei
Suzuki, Tomoya
Oda, Ayaka
Murahashi, Mutsunori
Fukuda, Takahiro
Shimoda, Masayuki
Murayama, Yuichi
Akasaki, Yasuharu
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-023-03482-8
- URN
-
urn:nbn:de:101:1-2023112112022624211687
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Takei, Jun
- Kamata, Yuko
- Tanaka, Toshihide
- Fukasawa, Nei
- Gomisawa, Kazutaka
- Satake, Mari
- Mori, Ryosuke
- Yamamoto, Yohei
- Suzuki, Tomoya
- Oda, Ayaka
- Murahashi, Mutsunori
- Fukuda, Takahiro
- Shimoda, Masayuki
- Murayama, Yuichi
- Akasaki, Yasuharu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Interstitial photodynamic therapy for newly diagnosed glioblastoma
Bench to bedside radiosensitizer development strategy for newly diagnosed glioblastoma
A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma
The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma
Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma
Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model
Feasibility of fractionated gamma knife radiosurgery in the management of newly diagnosed Glioblastoma
Early Therapeutic Interventions for Newly Diagnosed Glioblastoma: Rationale and Review of the Literature
Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma
Interstitial photodynamic therapy for newly diagnosed glioblastoma
Bench to bedside radiosensitizer development strategy for newly diagnosed glioblastoma
A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma
The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma
Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma
Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model
Feasibility of fractionated gamma knife radiosurgery in the management of newly diagnosed Glioblastoma
Early Therapeutic Interventions for Newly Diagnosed Glioblastoma: Rationale and Review of the Literature
Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma
Interstitial photodynamic therapy for newly diagnosed glioblastoma
Bench to bedside radiosensitizer development strategy for newly diagnosed glioblastoma
A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma
The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma
Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma
Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model
Feasibility of fractionated gamma knife radiosurgery in the management of newly diagnosed Glioblastoma
Early Therapeutic Interventions for Newly Diagnosed Glioblastoma: Rationale and Review of the Literature